Klaus Borner

Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis

Ralf Köhler, Heike Wulff, Ines Eichler et al. · Circulation · 2003 · 235 citations

Comparative Pharmacokinetics of Ciprofloxacin, Gatifloxacin, Grepafloxacin, Levofloxacin, Trovafloxacin, and Moxifloxacin after Single Oral Administration in Healthy Volunteers

Annette Lubasch, Ivonne Keller, Klaus Borner et al. · Antimicrobial Agents and Chemotherapy · 2000 · 183 citations · Full text

Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis

Nadja Schöler, Karsten Krause, Oliver Kayser et al. · Antimicrobial Agents and Chemotherapy · 2001 · 141 citations · Full text

Regular Analgesic Intake and the Risk of End-Stage Renal Failure

Wolfgang Pommer, Elisabeth Bronder, Eberhard Greiser et al. · American Journal of Nephrology · 1989 · 113 citations

West Berlin, Pain Medicine, Pharmacotherapy +20

Glucarpidase (Carboxypeptidase G2) Intervention in Adult and Elderly Cancer Patients with Renal Dysfunction and Delayed Methotrexate Elimination After High-Dose Methotrexate Therapy

Stefan Schwartz, Klaus Borner, K Müller et al. · The Oncologist · 2007 · 87 citations · Full text